Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - Histogen Inc. | Financial_Report.xls |
EX-31.1 - EX-31.1 - Histogen Inc. | d838509dex311.htm |
EX-32.2 - EX-32.2 - Histogen Inc. | d838509dex322.htm |
EX-31.2 - EX-31.2 - Histogen Inc. | d838509dex312.htm |
EX-10.14 - EX-10.14 - Histogen Inc. | d838509dex1014.htm |
10-K - FORM 10-K - Histogen Inc. | d838509d10k.htm |
EX-32.1 - EX-32.1 - Histogen Inc. | d838509dex321.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) | Registration Statement (Form S-8 No. 333-190134) pertaining to the Conatus Pharmaceuticals Inc. 2013 Incentive Award Plan, the Conatus Pharmaceuticals Inc. 2006 Equity Incentive Award Plan and the Conatus Pharmaceuticals Inc. 2013 Employee Stock Purchase Plan, and |
(2) | Registration Statement (Form S-3 No. 333-198142) of Conatus Pharmaceuticals Inc.; |
of our report dated March 13, 2015, with respect to the consolidated financial statements of Conatus Pharmaceuticals Inc. included in this Annual Report (Form 10-K) of Conatus Pharmaceuticals Inc. for the year ended December 31, 2014.
/s/ Ernst & Young LLP
San Diego, California
March 13, 2015